SeqLL (SQLLW) Competitors $0.0026 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends SQLLW vs. BIAFW, PRENW, STRRP, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, and ALVOShould you be buying SeqLL stock or one of its competitors? The main competitors of SeqLL include bioAffinity Technologies (BIAFW), Prenetics Global (PRENW), Star Equity (STRRP), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), and Alvotech (ALVO). These companies are all part of the "medical" sector. SeqLL vs. bioAffinity Technologies Prenetics Global Star Equity 180 Life Sciences 60 Degrees Pharmaceuticals Aclarion Ainos Alpha Tau Medical Alvotech Alvotech SeqLL (NASDAQ:SQLLW) and bioAffinity Technologies (NASDAQ:BIAFW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Is SQLLW or BIAFW more profitable? Company Net Margins Return on Equity Return on Assets SeqLLN/A N/A N/A bioAffinity Technologies N/A N/A N/A Which has higher earnings & valuation, SQLLW or BIAFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSeqLL$1.18KN/AN/AN/AN/AbioAffinity Technologies$7.32MN/AN/AN/AN/A Do analysts recommend SQLLW or BIAFW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeqLL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AbioAffinity Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community favor SQLLW or BIAFW? SeqLL and bioAffinity Technologies both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformSeqLLN/AN/AbioAffinity TechnologiesN/AN/A Does the media prefer SQLLW or BIAFW? In the previous week, bioAffinity Technologies had 2 more articles in the media than SeqLL. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for SeqLL. SeqLL's average media sentiment score of 0.00 equaled bioAffinity Technologies'average media sentiment score. Company Overall Sentiment SeqLL Neutral bioAffinity Technologies Neutral SummarybioAffinity Technologies beats SeqLL on 2 of the 2 factors compared between the two stocks. Ad Porter & CompanyThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you. Get SeqLL News Delivered to You Automatically Sign up to receive the latest news and ratings for SQLLW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SQLLW vs. The Competition Export to ExcelMetricSeqLLDiagnostics & Research IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$26.70M$5.18B$8.54BDividend YieldN/A5.44%5.06%4.17%P/E RatioN/A2.16101.9613.92Price / SalesN/A2,037.741,655.7394.67Price / CashN/A18.9533.9731.46Price / BookN/A2.374.744.61Net IncomeN/A$45.44M$116.42M$223.48M7 Day PerformanceN/A0.57%-1.07%-0.46%1 Month PerformanceN/A-8.12%5.32%3.85%1 Year PerformanceN/A17.24%33.43%26.12% SeqLL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SQLLWSeqLLN/A$0.00flatN/A-91.0%$0.00$1,177.000.007BIAFWbioAffinity TechnologiesN/A$1.00+27.9%N/AN/A$0.00$7.32M0.0010News CoveragePRENWPrenetics GlobalN/A$0.01+8.2%N/A-26.1%$0.00$22.66M0.001Gap UpSTRRPStar EquityN/A$9.15-1.0%N/A+0.2%$0.00$47.15M0.00171High Trading VolumeATNFW180 Life SciencesN/A$0.01flatN/A+9.0%$0.00N/A0.007SXTPW60 Degrees PharmaceuticalsN/A$0.02-61.2%N/AN/A$0.00$418,304.000.002Gap DownACONWAclarionN/A$0.03flatN/A-32.7%$0.00$53,947.000.007AIMDWAinosN/A$0.03-47.5%N/A-93.3%$0.00$65,122.000.0040Positive NewsDRTSWAlpha Tau MedicalN/A$0.18+8.7%N/AN/A$0.00N/A0.0080Gap UpALVOWAlvotechN/A$3.20+5.3%N/A+115.0%$0.00$306.77M0.004Gap DownALVOAlvotech2.5648 of 5 stars$13.02+0.3%$18.00+38.2%+45.5%$0.00$93.38M-4.911,026News Coverage Related Companies and Tools Related Companies bioAffinity Technologies Competitors Prenetics Global Competitors Star Equity Competitors 180 Life Sciences Competitors 60 Degrees Pharmaceuticals Competitors Aclarion Competitors Ainos Competitors Alpha Tau Medical Competitors Alvotech Competitors Alvotech Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SQLLW) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeqLL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SeqLL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
